ALAMYCIN LA 300 MG/ML SOLUTION FOR INJECTION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
05-01-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
OXYTETRACYCLINE BASIC
Available from:
Norbrook Laboratories Limited
ATC code:
QJ01AA06
INN (International Name):
OXYTETRACYCLINE BASIC
Dosage:
300 Mg/Ml
Pharmaceutical form:
Solution for Injection
Prescription type:
POM
Therapeutic group:
Bovine, Ovine, Porcine
Therapeutic area:
Oxytetracycline
Therapeutic indications:
Antibacterial
Authorization status:
Authorised
Authorization date:
1994-02-10
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Alamycin LA 300 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active Substance:
Oxytetracycline base
300 mg
(as Oxytetracycline dihydrate)
Excipients:
Sodium Formaldehyde Sulphoxylate
4.0 mg
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs and sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment and control of conditions caused by, or associated with, organisms sensitive to oxytetracycline
including:
_Bordetella bronchiseptica_
_Actinomyces pyogenes_
_Erysipelothrix rhusiopathiae_
_Pasteurella _spp.
_Staphylococcus _spp.
_Streptococcus _spp.
Certain mycoplasma, rickettsiae, protozoa and chlamydia.
Alamycin LA 300 may be used in the treatment and control of a wide range of common systemic, respiratory, urinary
and local infections caused by oxytetracycline sensitive organisms. Specific indications for Alamycin LA 300 include:
pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint-ill, navel-ill, supportive therapy in bovine mastitis, ovine
keratoconjunctivitis (pink-eye) and enzootic abortion in sheep.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 21/12/2015_
_CRN 7022548_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not dilute the Alamycin LA 300.
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
No special warnings.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
If concurrent treatment is administered use a separate injection site.
Use of the product should be based
Read the complete document
